本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trevi Therapeutics Inc.

6.98
+0.06500.94%
成交量:131.68万
成交额:922.13万
市值:6.74亿
市盈率:-14.85
高:7.16
开:6.87
低:6.73
收:6.91
数据加载中...
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]